Xencor Inc (NASDAQ:XNCR)
| 29.49 Delayed Data As of Dec 06 |  -0.02 / -0.07%Today’s Change | 19.36 Today|||52-Week Range 42.30 | -26.50% Year-to-Date |
Latest XNCR News | Press Releases
| Does Xencor (XNCR) Have the Potential to Rally 69% as Wall Street Analysts Expect? Nov 30 / Zacks.com - Paid Partner Content | Xencor (XNCR) Upgraded to Buy: Here's What You Should Know Nov 25 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 29.51 |
| Today’s open | 29.43 |
| Day’s range | 29.22 - 30.19 |
| Volume | 5,900 |
| Average volume (3 months) | 321,399 |
| Market cap | $1.8B |
Data as of 3:59pm ET, 12/06/2022
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -213.37% |
| Earnings growth (next 5 years) | +74.10% |
| Revenue growth (last year) | +124.23% |
| P/E ratio | 60.2 |
| Price/Sales | 8.82 |
| Price/Book | 2.49 |
Competitors
Data as of 4:00pm ET, 12/06/2022
Financials
| Next reporting date | February 28, 2023 |
| EPS forecast (this quarter) | -$0.77 |
| Annual revenue (last year) | $275.1M |
| Annual profit (last year) | $82.6M |
| Net profit margin | 30.04% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Monrovia, California |
Forecasts
